Cite
HARVARD Citation
Greco, C. et al. (2020). Target motion mitigation promotes high-precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: Results from a phase II study. Radiotherapy and oncology. pp. 21-28. [Online].